论文部分内容阅读
目的:探析影响糖尿病终末期肾病血液透析患者长期生存率的危险因素,进而帮助患者制定出提高生存率的方式。方法:我院于2015年6月至2017年6月将我院的39例糖尿病终末期肾病血液透析患者和39例非糖尿病终末期肾病血液透析患者作为研究对象,进而对两组患者的死亡率、死亡原因、并发症、营养状态及血生化改变进行比较分析。结果:通过研究可知,对照组1年和3年的死亡率分别为12.82%和38.46%,而观察组1年和3年的死亡率为10.26%和61.54%,观察组患者3年死亡率明显高于对照组。而在并发症发生率方面,观察组的发生率61.54%也明显高于对照组的38.46%,两组差异显著,具有统计学意义(P<0.05),结论:通过相应的研究可知,糖尿病终末期肾病血液透析患者的并发症发生率及死亡率均高于非糖尿病终末期肾病血液透析患者,因此为了提高糖尿病终末期肾病血液透析患者的长期生存率,必须积极进行并发症的救治工作,从而促进患者恢复健康。
Objective: To explore the risk factors influencing the long-term survival rate of patients with end-stage renal disease (HDRD) and to help patients to develop ways to improve the survival rate. Methods: From June 2015 to June 2017, 39 cases of diabetic end-stage renal hemodialysis patients and 39 cases of non-diabetic end-stage renal disease hemodialysis patients in our hospital were studied. The mortality of the two groups , Causes of death, complications, nutritional status and blood biochemical changes were compared. Results: According to the study, the 1-year and 3-year mortality rates in the control group were 12.82% and 38.46%, while the 1-year and 3-year mortality rates in the observation group were 10.26% and 61.54% respectively. The 3-year mortality rate in the observation group was significantly Higher than the control group. The complication rate, the incidence of observation group was 61.54% was significantly higher than the control group of 38.46%, the difference between the two groups was statistically significant (P <0.05), Conclusion: Through the appropriate study shows that the end of diabetes Complications and mortality rates in patients with end-stage renal disease are higher than those in non-diabetic patients with end-stage renal disease. Therefore, in order to improve the long-term survival rate of patients with end-stage renal disease, we must actively carry out the treatment of complications Promote patient recovery.